Home Therapeutics Biologics

Biologics

Latest
Lonza will increase its mid-scale biologics manufacturing capacity as part of an expansion of its Portsmouth
Biologics

Lonza to Expand Mid-Scale Biologics Manufacturing Capacity in Portsmouth, NH

Source: NIH
Biologics

Alzheimer’s Amyloid Drug Fails to Slow Cognitive Decline in Clinical Trial

Clover Biopharmaceuticals has selected GE Healthcare's FlexFactory™ single-use biomanufacturing platform for its new facility in Changxing
Biologics

Clover Biopharmaceuticals Selects GE Healthcare’s FlexFactory for New Facility

In the SLAY method
Biologics

Engineered Bacteria Manufacture and Screen Antimicrobial Peptides against Themselves

Biologics

Evolutionary Backtrack Offers Up Novel Rheumatoid Arthritis Candidate

Source: Kjetil Ree/Wikimedia
Biologics

Gates Foundation Invests up to $40M in Immunocore to Develop TCR-Based...

Biologics

FDA Lays Out Which Postapproval Manufacturing Changes for Biologics Are ‘Minimal’

Biologics

Seattle Genetics Acquires BMS Manufacturing Site in Bothell, WA

Biologics

Lonza Starts Construction on Biological Manufacturing and Development Complex

Biologics

Win More Biologics Development Battles with Early Stability Analysis

Load more

Recently Featured

Stay Connected

557,135FansLike
46,479FollowersFollow
Copyright © 2019 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up